MY DOCTOR TELLS

When (pharmaceutical) market dominates and sponsors research activities in Universities, it is believed that the scientific study thus published is biased in favor of the pharma companies. I am of the opinion that half 1/2 or 1/3 rd of the American Women are projected to be having Sexual Dysfunction.

Is it not possible that this 1/2 of women labeled as having Female Sexual Dysfunction have more need of romance in relationships to be able to not fall technically into the category of Female Sexual Dysfunction? Or, is it not possible that this 1/2 of women population are totally normal and that the medicos should change their definition of FSD.  Instead of recognizing and acknowledging that women with FSD as defined today, for example, hypoactive sexual desire, is biologically normal.

\Why not FIRST study NORMAL FEMALE SEXUAL RESPONSE? Come to a consensus. Then on the basis of what is acknowledged as normal, scientists can define FEMALE SEXUAL DYSFUNCTION. The demographic study thus published will be closer to reality being based on accepted criteria of Woman’s Normal Sexuality.

Apparently after the hype and deluge of Viagra (c) since 1998, the pharmaceutical companies have been  desperately looking for similar sensational drug, which would be a best seller. This search influences definition of Female Sexual Dysfucntions. Even after a decade pharmaceutical companies have not seized any single drug comparable to Viagra (c).

Dr. Ashok Koparday, Consultant in Psycho Sexual Medicine believes that this 30 % to 50 % who are labeled today as Female Sexual Dysfunctions are not abnormal. Instead, they are other separate group of normal sexual behavior in women.
Authors Jennifer R. Berman, Javier Bassuk
¹UCLA Medical Center, Female Sexual Medicine Center, 924 Westwood Blvd., Suite 515, Los Angeles, CA 90024, USA